Plasma histamine levels and symptoms in double blind placebo controlled histamine provocation

Inflammation Research

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Giera, B ^a   Straube, S ^a   Konturek, P ^a   Hahn, E G ^a   Raithel, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; PLACEBO;

BLOOD PRESSURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIARRHEA; DYSPNEA; EDEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART RATE; HEAT SENSATION; HISTAMINE BLOOD LEVEL; HUMAN; MAXIMUM PLASMA CONCENTRATION; METEORISM; NOSE MUCOSA; PROVOCATION TEST; STOMACH PAIN; SYMPTOM; VERTIGO;

DOUBLE-BLIND METHOD; HISTAMINE; HUMANS; HYPERSENSITIVITY; PLACEBOS; RANDOM ALLOCATION;

EID: 43249094399     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-0636-9     Document Type: Conference Paper

References (3)

1. Jarisch R, Götz M, Hemmer W, Missbichler A, Raithel M, Wantke F. Histamin - Intoleranz. Histamin und Seekrankheit. 2ed Stuttgart, New York: Thieme Verlag 2004.
2. Kuefner MA, Schwelberger HG, Weidenhiller M, Hahn EG, Raithel M. Both catabolic pathways of histamine via histamine - N - methyltransferase and diamine oxidase are diminished in the colonic mucosa of patients with food allergy. Inflamm Res 2004; 53: S31-S2.
3. Weidenhiller M, Traenkner A, Schwab D, Hahn EG, Raithel M. Different kinetics of mediator release can be detected during allergic reactions after oral provocation (double blind placebo - controlled food challenge). Inflamm Res 2002; 51 Suppl 1: 29-30.